Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd 2023 AR2
The report outlines Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.'s financial and operational performance for the fiscal year 2023, alongside its environmental and social responsibility initiatives. The company achieved steady growth with an operating income of RMB 75.52 billion, representing a 6.68% increase year-on-year. Key highlights include the completion of major industrial bases, such as the chemical pharmaceutical project in Zhuhai, and the establishment of the first pilot QFLP fund in Guangzhou. Additionally, the company advanced its digital transformation, optimized procurement strategies to reduce costs, and actively participated in rural revitalization and environmental protection efforts.
Company: Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Sector: Health Care
Country: China
Year: 2023
Type: AR2
Pages: 517
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Annual Report
The report outlines Guangzhou Baiyunshan Pharmaceutical Holdings Co., Ltd.'s financial and operational performance for the fiscal year 2023, alongside its environmental and social responsibility initiatives. The company achieved steady growth with an operating income of RMB 75.52 billion, representing a 6.68% increase year-on-year. Key highlights include the completion of major industrial bases, such as the chemical pharmaceutical project in Zhuhai, and the establishment of the first pilot QFLP fund in Guangzhou. Additionally, the company advanced its digital transformation, optimized procurement strategies to reduce costs, and actively participated in rural revitalization and environmental protection efforts.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2023
Reporting Period
Jan 1, 2023 - Dec 31, 2023
Fiscal Year
2023
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Employees